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Background: 
Interventional pain management (IPM) is a branch of medical science that deals with management of painful 
medical conditions using specially equipped X-ray machines and anatomical landmarks. Interventional physiatry 
is a branch of physical medicine and rehabilitation that treats painful conditions through intervention in 
peripheral joints, the spine, and soft tissues.
Methods: 
A cross-sectional study was conducted using three years of hospital records (2006 to 2008) from the Physical 
Medicine and Rehabilitation Department at Chittagong Medical College Hospital in Bangladesh, with a view 
toward highlighting current interventional pain practice in a tertiary medical college hospital. 
Result: 
The maximum amount of intervention was done in degenerative peripheral joint disorders (600, 46.0%), 
followed by inflammatory joint diseases (300, 23.0%), soft tissue rheumatism (300, 23.0%), and radicular or 
referred lower back conditions (100, 8.0%). Of the peripheral joints, the knee was the most common site of 
intervention. Motor stimulation-guided intralesional injection of methylprednisolone into the piriformis muscle 
was given in 10 cases of piriformis syndrome refractory to both oral medications and therapeutic exercises. 
Soft tissue rheumatism of unknown etiology was most common in the form of adhesive capsulitis (90, 64.3%), 
and is discussed separately. Epidural steroid injection was practiced for various causes of lumbar radiculopathy, 
with the exception of infective discitis. 
Conclusion: 
All procedures were performed using anatomical landmarks, as there were no facilities for the C-arm/dia-
gnostic ultrasound required for accurate and safe intervention. A dedicated IPM setup should be a requirement 
in all PMR departments, to pr ovide better pain management and to r educe the bur den on other specialties. 
(Korean  J  Pain  2011;  24:  205-215)
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INTRODUCTION
    According to the American Society of Interventional 
Pain Physicians (ASIPP), interventional pain management 
(IPM) is a “discipline of medicine devoted to the diagnosis 
and treatment of pain related disorders.” IPM utilizes a 
multidisciplinary approach in which a team of health care 
professionals  works  together  to  provide  a  full  range  of 
treatments and services for patients suffering from chronic 
and/or acute pain. The goals of IPM are to relieve, reduce, 
or manage pain and improve a patient’s overall quality of 
l i f e  t h r o u g h  m i n i m a l l y  i n v a s i v e  t e c h n i q u e s  s p e c i a l l y  d e-
signed to diagnose and treat painful conditions. The dis-
cipline also strives to help patients return to their everyday 
activities quickly and without heavy reliance on medications. 
The team members of IPM include a physiatrist (physical 
medicine  and  rehabilitation  specialist),  anesthesiologist, 
general surgeon, internist, and psychiatrist [1]. Interven-
tional physiatry is a branch of physical medicine and re-
habilitation that treats pain using precisely placed anti-in-
flammatory injections into the spine and pelvis, guided by 
specially  equipped  X-ray  machines  [2,3].  Interventional 
pain physicians may perform selective nerve root blocks, 
facet joint procedures, spinal cord stimulation, epidural in-
jections, intrathecal pump placement, trigger point proce-
dures, and vertebroplasty. They can also perform disc pro-
cedures such as discography, provocative discography, in-
tradiscal electrothermaltherapy (IDET), etc. [3,4]. In 1998, 
the American Board of Physical Medicine and Rehabilita-
tion joined the American Board of Anesthesiology in rec-
ognition of pain management as an interdisciplinary sub-
s pecia l ty [4,5]. In Bangla d esh, h o w e v er, th e situ ation is 
completely different, with some limited spinal and periph-
eral joint procedures being performed by different special-
ists (physiatrists, orthopedists, anesthesiologists, neurolo-
gists, etc.) in their private practices. The subspecialty of 
interventional pain management does not exist, and there 
are no institutes devoted solely to IPM. In this article, we 
focus on the current practice of IPM in a tertiary medical 
college hospital in Bangladesh.
MATERIALS  AND  METHODS 
    Patients who visited and received treatment through 
a pain clinic in the Department of Physical Medicine and 
Rehabilitation (PMR) at Chittagong Medical College Hospital 
over a period of 3 years (2006-2008) were enrolled in the 
study. Sources of patients were the outpatient department 
(PMR OPD), and the rheumatology follow up clinic, spondy-
l a r t h r o p a t h y  ( S p A )  c l i n i c ,  a n d  r h e u m a t o i d  a r t h r i t i s  ( R A )  
clinic, conducted in the department on separate days. Data 
were collected and recorded on a formulated data sheet 
containing  each  patient’s  p a r t i c u l a r  a n d  c l i n i c o - r a d i o -
logical information. To facilitate description, patients were 
categorized into the following 4 groups:
    G-A: Degenerative peripheral joint disorders 
    G-B: Inflammatory rheumatological disorders
    G-C: Non-infectious and non-inflammatory soft tis-
sue rheumatism (STR)
    G-D: Radicular and referred lower back pain (LBP)
    Inflammatory joint disorders were classified according 
t o  t h e  f o l l o w i n g  c l i n i c a l  c r i t e r i a :  1 9 8 7  r e v i s e d  A m e r i c a n 
College of Rheumatology (ACR) criteria for RA; modified 
N e w  Y o r k  c r i t e r i a  f o r  a n k y l o s i n g  s p o n d y l i t i s  ( A S ) ;  a n d  
European Spondylarthropathy Study Group criteria for SpA 
[6-8]. Degenerative knee conditions were diagnosed ac-
cording to clinical findings, with recommended clinical cri-
teria used in some cases (A CR criteria for knee osteo-
arthritis, OA) [9]. Radiological corroboration was done where 
necessary. Pain in between the 12
th  rib and the inferior 
gluteal folds is known as LBP [10], and the common mus-
culoskeletal sources of LBP are lumbar spondylosis, lumbar 
spinal stenosis, prolapsed lumbar intervertebral disc (PLID), 
myofascial pain syndrome (MPS), fibromyalgia (FMS), lum-
bar  ligamentous  sprain,  piriformis  syndrome,  sacroiliac 
joint  dysfunction,  AS,  vertebral  body  fracture,  and 
spondylodiscitis. The term lumbar spinal stenosis is used 
to describe abnormal narrowing of the central part, lateral 
recesses, or intervertebral foramen of the lumbar spine to 
the point where the neural elements are compromised and 
signs or symptoms develop in the lower limbs. Common 
causes of lumbar spinal stenosis are lumbar spondylosis, 
lumbar spondylolisthesis, ligamentum flavum hypertrophy, 
facet joint arthropathy, PLID, and spondylodiscitis [10, 11]. 
All of these clinical conditions except infective discitis were 
treated with interventional procedures in the pain clinic. 
Ligamentum  flavum  hypertrophy/facet  hypertrophy  was 
diagnosed with lumbar spine MRI. Soft tissue lesions can 
be due to trauma, overuse, infection, inflammation, or en-
docrinopathy, or may be idiopathic. In this paper, non-in-
fectious and non-inflammatory soft tissue rheumatism are 
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Table 1. Demographic Characteristics of All Patients
Sex 
  Male 683 (54.2)
  Female 577 (45.8)
Age groups (years)
  0−10   3 (0.2)
  11−20  47 (3.7) 
  21−30 115 (9.1)
  31−40 175 (13.9)
  41−50 470 (37.3)
  51−60 398 (31.6)   
  ＞60  52 (4.0)  
Occupation 
  Housewife 536 (42.5) 
  Jobless/retired 215 (17.1)
  Farmer 175 (13.9) 
  O f f i c i a l  w o r k e r  7 3  ( 5 . 8 ) 
  Student  62 (4.9) 
  Shopkeeper  61 (4.8) 
  Businessman  48 (3.8) 
  Mechanical worker  42 (3.3)
  Garments worker  26 (2.1) 
Sources of patient
  PMR OPD 500 (39.7)
  Rheumatology follow up clinic 280 (22.2)
  RA follow up clinic 130 (10.3)
  SpA clinic 110 (8.7)
  Referral 240 (19.0)
    Internal medicine 200 (83.3)
    Pediatric medicine  20 (8.3)
    Dermatology OPD  10 (4.2)
    Ophthalmology  10 (4.2)
Values are number of patients (percentage). PMR OPD: physical 
medicine and rehabilitation outpatient door, RA: rheumatoid arthritis,
SpA: spondylarthropathy. 
1. Medications and procedures
    The medications used for intervention were gluco-
corticoid derivatives (triamcinolone or methylprednisolone) 
and local injections of lidocaine [12]. Steroid doses ranged 
from 20-160 mg, with the maximum dosage (160 mg) given 
in lumbar interlaminar epidural injections and the minimum 
(20 mg) in intralesional (IL) procedures. During intra- 
articular (I/A) injection, large joints, medium-sized joints, 
and small joints received 40-80 mg, 20-40 mg, and 20 
mg, respectively. Along with steroid injections, 1% lidocaine 
was used in a 2：1 ratio. The presence of effusion in the 
knee joint was determined by massage test (mild effusion), 
patellar tap (moderate effusion), and fluctuation test (huge 
effusion) [13]. Knee joint intervention was done with a lat-
eral approach using a 22 G needle. In cases of OA of the 
knee, viscosupplement injection of sodium hyaluronate 20 
mg/2 ml was used in some patients. Following knee inter-
vention (both I/A steroid and viscosupplement), the joint 
was wrapped with a crepe bandage and movement was re-
stricted for at least 24 hours. In the shoulder joint, both 
anterior and posterior approaches were employed. In the 
ankle joint, procedures wereperformed just medial to the 
tibialis anterior tendon. During lumbar epidural injections, 
80-160 mg of steroid was placed in the epidural space us-
ing the LOR (loss of resistance) technique. These injections 
were usually performed at the L3-4 level, and sometimes 
at the L2-3 or L4-5 level due to difficulty with penetration 
at the L3-4 level. The epidural injections were performed 
in the prone position, with abdominal support to make the 
lumbar interlaminar space wider [14,15]. In the case of IL 
infiltration, the dose of steroid used ranged from 20-80 
mg/infiltration, with the minimum in trigger finger (20 mg) 
and the maximum in piriformis syndrome (80 mg). During 
IL procedures, direct injection into the tendon sheath was 
avoided. In piriformis syndrome, the patient was placed in 
the prone position and the procedure was performed at the 
junction of the lateral one third and medial two thirds of 
the imaginary line between the greater trochanter and the 
intersection of the upper two thirds and lower one third 
of the sacroiliac joint, and the muscle was identified using 
anatomical landmarks, in some cases with motor stim-
ulation [16]. Joint procedures were performed with methyl-
prednisolone, whereas soft tissue intervention was done 
with  triamcinolone  acetonide  except  in  cases  of  plantar 
fascia, in which methylprednisolone was preferred. Following 
intervention, antibiotic flucloxaciline (250-500 mg 4 times/ 
day for 5 days) was prescribed. In immunocompromised 
patients, antifungal fluconazole (50 mg/day for 2 weeks) 
was added. Acute flare-ups of polyarticular or oligoarticular 
rheumatological  conditions  were  managed  with  pulsed 
methylprednisolone (1,000 mg/day) in 100 ml of 5% dex-
trose aqua and treated for 3 consecutive days. Finally, a 
descriptive (cross-sectional) study was conducted using all 
medical records. The Bangladesh College of Physicians and 
Surgeons had reviewed and accepted all of these activities 
conducted in the department. 
RESULTS
    During the study period, a total of 45,842 patients 
were treated in the PMR OPD. Out of these patients, 1,260 208 Korean J Pain Vol. 24, No. 4, 2011
Fig. 1. Interventional pain management in different rheuma-
tological conditions. DJD: degenerative peripheral joint 
disorders, STR: soft tissue rheumatism, IRC: inflammatory 
rheumatological conditions, R.LBP: radicular low back pain.
Table 2. Degenerative Peripheral Joint Disorders
Diagnosis 
  OA knee
  OA hip
  OA acromioclavicular joint
OA knee
  Unilateral
  Bilateral 
  PFJ
  TFJ
  PFJ ＋ TFJ
Knee joint effusion
  Massage test (bulge sign)
  Patellar tap
  Fluctuation test
  Baker’s cyst
  No effusion
OA hip
  Unilateral
  Bilateral 
OA acromioclavicular joint
  Unilateral
  Bilateral 
Injection sodium hyaluronate (20 mg/2 ml) 
  3 injection
  2 injection
  1 injection 
Complications*
  Aspiration pain
  Recurrent effusion
  Flaring up
  Swollen leg 
  Skin depigmentation 
510 (85.0)
50 (8.3)
40 (6.7)
300 (58.8)
210 (41.2)
260 (51.0)
150 (29.4)
100 (19.6)
470 (92.2)
 50 (10.6)
210 (44.7)
110 (23.4)
100 (21.3)
40 (7.9)
50 (8.3)
 46 (92.0)
 4 (8.0)
40 (6.7)
 35 (87.5)
  5 (12.5)
10 (1.7)
  2 (20.0)
  5 (50.0)
  3 (30.0)
470 (78.3)
450 (95.7)
 60 (12.8) 
36 (7.7) 
09 (1.9)
Values are number of patients (percentage). OA: osteoarthritis, 
PFJ: patella-femoral joint, TFJ: tibio-femoral joint. *Overlap pre-
sentation.
(2.8%)  with  different  articular  and  non-articular  clinical 
conditions underwent intervention in the pain clinic. The 
patients’ demographic profile is presented in Table 1. The 
g r e a t e s t  n u m b e r  o f  p a t i e n t s  c a m e  f r o m  t h e  P M R  O P D 
(500, 39.7%), followed by the rheumatology follow up clinic 
(280, 22.2%), RA clinic (130, 10.3%), and SpA clinic (110, 
8.7%). 240 patients (19.0%) were referred from different 
departments of the facility for better management, includ-
ing rehabilitative support. Among the 1260 patients, de-
generative peripheral joint disorders were the most com-
mon  diagnosis  (600,  46.0%),  followed  by  inflammatory 
rheumatological conditions (300, 23.0%), non-infectious/ 
non-inflammatory soft-tissue rheumatism (300, 23.0%), 
and radicular/referred LBP (100, 8.0%) (Fig. 1). These are 
discussed separately below. 
1. G-A: Degenerative peripheral joint disorders
    A total of 600 patients with diff eren t degenerativ e pe-
ripheral joint disorders (Table 2) were treated in the pain 
clinic. O A of th e knee w as th e m os t fr equ en t con dition 
(510, 85%), followed by OA of the hip (50, 8.3%) and OA 
of the acromioclavicular joint (40, 6.7%). In cases of OA 
of the knee, unilateral presentation was seen in 300 cases 
and bilateral presentation was seen in 210 cases. The pa-
tello-femoral joint (PFJ) and tibio-femoral joint (TFJ) were 
involved in 260 and 150 cases, respectively. Both the PFJ 
and TFJ joints were involved in 100 cases (19.6%). The knee 
j o i n t  w a s  d e f o r m e d  i n  1 0 0  c a s e s ,  a n d  a s s o c i a t e d  j o i n t  
mouse or loose body was found in 29 patients. Presence 
of  knee  joint  effusion  was  diagnosed  by  massage  test, 
fluctuation test, and patellar tap in 50, 150, and 310 cases, 
respectively. In 40 patients there was no sign of effusion. 
A Baker’s cyst was found to be present in 100 cases. Joint 
intervention was done with injection of methylprednisolone 
(40-80 mg) in OA of the knee and acromioclavicular joint, 
but  not  in  the  hip.  Injection  of  sodium  hyaluronate  20 
mg/2ml was also given in 10 patients with OA of the knee 
refractory to I/A steroids. Out of these 10 patients, only 
2 received the recommended dose (at least 3 injections in 
a single joint for 3 consecutive weeks). 5 patients received MAB Siddiq, et al / Physiatric Experience in Pain Intervention 209
Table 3. Inflammatory Rheumatological Disorders
Diagnosis 
  R A
  S p A
  J I A
  CI A
Total joints 
  K n e e
  An k l e
  S h o u l d e r 
  Metatarsophalangeal joint
Soft tissue lesion
  P l a n t a r  f a s c i t i s 
  de Quervain’s tenosynovitis
  Compressive neuropathy
  T r i g g e r  f i n g e r
Steroid dose
  P e r i p h e r a l  j o i n t  ( 4 0−80 mg)
  Intra-lesional (20−80 mg)
  Pulsed steroid (1,000 mg/day)
Complications 
  As p i r a t i o n  p a i n
  F l a r i n g  u p
  Skin depigmentation
  Recurrent effusion
140 (46.7)
120 (40.0)
 30 (10.0)
10 (3.3)
319
160 (50.2)
100 (31.3)
 49 (15.4)
10 (3.1)
 56 (18.7)
 30 (10.0)
10 (3.3)
10 (3.3)
 6 (2.0)
319 (100)
 56 (18.7)
10 (3.3)
140 (46.7)
120 (85.7)
10 (7.1)
 5 (3.6)
 5 (3.6)
Values are number of patients (percentage). RA: rheumatoid 
arthritis, SpA: spondylarthropathy, JIA: juvenile idiopathic arthritis,
CIA: crystal induced arthritis.
2 and 3 patients received 1 injection. During and following 
joint procedures, complications were reported in 470 cases 
(78 . 3% ),  a n d  t h e d is t ri b u t i o n w a s:  a s p i r a t i o n p a i n (4 5 0 , 
95.7%),  recurrent  effusion  (60,  12.8%),  swollen  leg  (36, 
7.7%), flare-ups (36, 7.7%), and skin depigmentation (9, 
1.9%). Aspiration pain was common in the middle of the 
procedure. Recurrent effusion was common in deformed 
knee joints (58), with or without loose bodies in the joint. 
Flaring Flare-ups were common in OA of the knee treated 
with dry aspiration (27) during the first 24 hours following 
the procedure, and were managed with local ice application 
and diclofenac suppository (50 mg) when needed. Swollen 
leg following aspiration was mostly due to knee bandaging 
causing tight compression over popliteal vessels, resulting 
in a transient impairment of venous return and peripheral 
edema. There was no post-procedural joint infection.
2. G-B: Inflammatory rheumatological disorders
    A total of 300 cases of different inflammatory rheu-
matological conditions (Table 3) were treated through in-
tervention in different peripheral joints and soft tissues. 
Among these patients, the most frequent condition was RA 
(140, 46.7%), followed by SpA (120, 40.0%), juvenile idio-
pathic arthritis (30, 10.0%), and crystal induced arthritis 
(CIA) (10, 3.3%). Among patients with crystal arthritis, 8 
cases were classified as gout and the other 2 were classi-
fied as pseudogout. As there were no facilities for crystal 
identification, synovitis was diagnosed on the basis of clin-
i c a l  e x a m in a t i o n  o n l y . R o u t in e s c r ee n i ng f o r s e r um  u ri c 
acid and creatinine was also done in all suspected cases 
of CIA. Peripheral joint intervention was most common in 
the knee (160, 50.2%), followed by the ankle (100, 31.3%), 
shoulder  (49,  15.4%),  and  1
st  metatarsophalangeal  joint 
(10, 3.1%). In addition to inflammatory peripheral joints, 
intervention was also done in inflammatory soft tissue, and 
c o m m o n l y  p e r f o r m e d  i n  p l a n t a r  f a s c i a  ( 3 0 ,  1 0 . 0 % ) ,  d e  
Quervain’s tenosynovial sheath (10, 3.3%), and trigger fin-
ger (6, 2.0%). All cases of plantar fasciitis were found in 
SpA variants. Trigger finger and de Quervain’s tenosyno-
vitis were classified as RA. Compressive neuropathy in the 
form of carpal tunnel syndrome (CTS) was also seen in 10 
cases of RA. During and after intervention, common com-
plications  were joint aspiration pain (120, 85.7%), acute 
flare-up (10, 7.1%), skin depigmentation (5, 3.6%), and re-
current effusion (5, 3.6%). Aspiration pain was common in 
the knee joint at the mid point of the procedure. Pulsed 
steroids were given in 10 patients (3.3%) with RA or SpA 
during their acute flare-ups.
3. G-C: Non-infectious and non-inflammatory soft tissue 
rheumatism (STR)
    A total of 300 cases of STR (T able 4) were treated 
in this OPD, and are discussed under the following catego-
ries: idiopathic, endocrinopathy, OA of the knee, and trau-
ma and overuse soft tissue lesion. Soft tissue lesion due 
to overuse and trauma was seen in 50 cases, and com-
monly involved the elbow (15, 30.0%), de Quervain’s teno-
synovial sheath (10, 20.0%), plantar fascia (5, 10.0%), bi-
cipital tendon (5, 10.0%), and lower back, in which case 
the cause was lumbar ligamentous sprain (5, 10.0%). Soft 
tissue lesion of unknown etiology was found in 190 cases 
(63.3%),  and  common  diagnoses  were  frozen  shoulder 
(adhesive  capsulitis)  (90),  MPS  (50),  tennis  elbow  (20), 
c o m p r e s s i v e  n e u r o p a t h y  ( 2 0 ) ,  a n d  p l a n t a r  f a s c i i t i s  ( 1 0 ) .  
MPS was most frequently found (27) in and around the 
scapulothoracic  junction.  Adhesive  capsulitis  was  found 210 Korean J Pain Vol. 24, No. 4, 2011
Table 4. Non-infectious/non-inflammatory Soft Tissue Rheumatism
Idiopathic
  Frozen shoulder syndrome
  Myofascial pain syndrome
  Tennis elbow
  P l a n t a r  f a s c i t i s
  Compressive neuropathy
    Carpal tennel syndrome
    Me r a l g i a  p a r e s t h e t i c a
    Mo r t o n ’ s  n e u r o ma
Endocrinopathy 
  Trigger finger-trigger thumb
  Compressive neuropathy
Trauma and overusesoft tissue lesion
  Tennis elbow 
  de Quervain’s tenosynovitis
  Bi c i p i t a l  t e n d o n
  P l a n t a r  f a s c i a
  Lumbar ligamentous sprain 
  Compressive neuropathy
    Ca r p a l  t u n n e l  s y n d r o me
    Tarsal tunnel syndrome
Degenerative knee condition
  Anserine bursitis
  Double crush phenomenon
Associated risk factors in FSS
  Hy p e r t e n s i o n  ( HT N)
  Diabetes mellitus (DM)
  HT N ＋ DM
  Ischemic heart disease
  S t r o k e 
  Hypothyroidism
Complications*
  Skin depigmentation
  R e c u r r e n c e
  F l a r i n g  u p
  F a i l u r e 
190 (63.3)
 90 (47.4)
 50 (26.3)
 20 (10.5)
10 (5.3)
 20 (10.5)
 15 (75.0)
  4 (20.0)
 1 (5.0)
 50 (20.0)
 35 (70.0)
 15 (30.0)
 50 (20.0)
 15 (30.0)
 10 (30.0)
  5 (10.0)
  5 (10.0)
  5 (10.0)
 10 (20.0)
  5 (10.0)
  5 (10.0)
10 (4.0)
  5 (50.0)
  5 (50.0)
 70 (50.0)
 15 (21.4)
 15 (21.4)
 20 (28.6)
 10 (14.3)
 5 (7.1)
 5 (7.1)
 29 (11.6)
 20 (69.0)
 10 (34.5)
02 (6.9)
02 (6.9)
Values are number of patients (percentage). FSS: frozen shoulder
syndrome. *Overlap presentation.
Table 5. Radicular LBP
Dermatomal LBP
  Average duration of initiation of action (days)
  Average duration of achieving ＞70% 
 pain reduction (days)
  Patient’s reported pain score reduction ＞70%
  Patient’s reported pain score reduction ＜50%
Non-dermatomal LBP
  Average duration of initiation of action (days)
  Average duration of achieving ＞70% 
   pain reduction (days)
  Patient reported pain score reduction ＞70%
  Patient reported pain score reduction ＜50%
Causes of dermatomal LBP
  Degenerative disc disease
  Prolapsed lumbar intervertebral disc 
  Spondylolisthesis
  Vertebral body fracture
  Spondylodiscitis
Cause of non-dermatomal LBP
  Piriformis syndrome 
    Unilateral
    B i l a t e r a l  
Lumbar interlaminar epidural
  L3-4
  L4-5 
  L2-3
Complications*
  Multiple prick for epidural
  Headache
  Partial recovery
  Recurrence
50 (83.3)
 5
20 
45 (95.0)
5 (5.0)
10 (16.7)
3 
20 
 6 (60.0)
 3 (30.0)
50
31 (62.0)
12 (24.0)
 5 (10.0)
1 (2.0)
1 (2.0)
10
 9 (90.0)
 1 (10.0)
49
35 (71.4)
10 (20.4)
4 (8.2)
25 (40.6)
 7 (28.0)
 5 (20.0)
 8 (32.0)
 7 (28.0)
Values are number of patients (percentage). LBP: low back pain. 
*Overlap presentation.
with  some  co-morbid  conditions,  such  as  hypertension, 
DM, ischemic heart disease, stroke, and hypothyroidism. 
In endocrinopathy, STR was found in 50 cases, in the form 
of  trigger  finger/trigger  thumb  (35,  70.0%)  and  com-
pressive neuropathy (15, 30.0%). Compressive neuropathy 
due  to  trauma/overuse  was  diagnosed  in  10  patients 
(20.0%). Other than endocrinopathy and trauma/overuse, 
compressive neuropathy was also seen in the double crush 
phenomenon, and common diagnoses were CTS, tarsal tun-
nel  syndrome  (TTS),  meralgia  paresthetica,  and  Morton’s 
neuroma. All 5 cases of TTS were found in lumbar spinal 
stenosis  with  a  diagnosis  of  double  crush  phenomenon. 
Anserine bursitis was diagnosed in 5 cases of OA of the 
knee. Following IL steroid injection, reported complications 
w e r e  s k i n  d e p i g m e n t a t i o n  ( 2 0 ,  6 9 . 0 % ) ,  r e c u r r e n c e  ( 1 0 ,  
34.5%),  acute flare-up  (2, 6.9%),  and failure (2, 6.9%). 
Skin depigmentation was common with procedures using 
triamcinolone in de Quervain’s tenosynovial sheath. 
4. G-D: Radicular and referred low back pain 
    During the study period, a total of 100 patients with 
radicular and referred LBP were seen in the pain clinic. Out 
of these, 60 patients had radicular pain, and the remaining 
40 had referred LBP. Sources of referred LBP were facet 
arthropathy, lumbar sacralization forming pseudoarthrosis 
with the sacrum, and sacroiliac arthropathy or dysfunc-MAB Siddiq, et al / Physiatric Experience in Pain Intervention 211
tion, diagnosed in 26, 9, and 5 cases, respectively. There 
w a s  n o  i n t e r v e n t i o n  e i t h e r  i n  f a c e t  o r  s a c r o i l i a c  j o i n t s .  
Radicular LBP (Table 5) was broadly categorized into two 
g r o u p s ,  d e r m a t o m a l  a n d  n o n - d e r m a t o m a l .  A  c o m m o n  
presentation of dermatomal radiculopathy was lumbar spi-
nal stenosis (50, 83.3%), due to degenerative disc disease 
(31, 62.0%), PLID (12, 24.0%), spondylolisthesis (5, 10.0%), 
spondylodiscitis (1, 2.0%), and vertebral body fracture (1, 
2.0%). Among 50 cases of lumbar stenosis epidural steroid 
injection was given in 49 cases, no injection in spondy-
lodiscitis. For dermatomal radiculopathy, lumbar epidural 
injections were given at the L3-4, L4-5, and L2-3 level 
in 35 (71.4%), 10 (20.4%), and 4 (8.2%) cases, respectively. 
As most of our patient could not understand V AS (visual 
analogue scale, 0-100 mm) for pain, a NRS (numerical 
rating scale, 0-100 mm) was used to report changes of 
pain after epidural injection where 0 indicates no pain and 
100 indicates maximum pain. Before injection, all patients 
considered their pain as 100 mm (100%) and asked to rate 
their pain reduction by percentage after injection. At least 
50% reduction of initial pain score within 3 weeks was de-
fined as improvement. In our study subject, after epidural 
injection pain began to reduce at the end of the first week 
(mean 5 days). Out of 49, 45 patients reported 70% reduc-
tion of pain at third week of follow up (mean 20 days) and 
this improvement was maintained at least 6 months in 27 
cases. On the other hand 70% pain reduction was sus-
tained for mean 4 months in another 13 patients (26.0%), 
and all they needed a second dose of epidural steroid by 
this time. The patients’ reported pain reduction score was 
below 50% in 4 cases of spondylolisthesis. Long-term data 
were not available in 4 patients of lumbar stenosis. Pirifor-
mis syndrome was the only cause of non-dermatomal rad-
icular LBP, and was diagnosed in 10 patients (16.7%). Out 
of these, 6 patients gained 70% pain reduction after inter-
v e n t i o n ,  a n d  t h i s  i m p r o v e m e n t  w a s  m a i n t a i n e d  f o r  a n  
average of 3 months with muscle relaxants (tolperison, cy-
c l o b e n z a p r i n e ,  o r  b o t h ) .  C o m m o n  p r o c e d u r a l  a n d  p o s t - 
p r o c e d u r a l  c o m p l i c a t i o n s  w e r e  m u l t i p l e  p r i c k s  i n  l u m b a r 
epidurals (7, 28.0%), headache (5, 20.0%), partial recovery 
(8, 32.0%), and recurrence within 3 months (7, 28.0%). 
DISCUSSION
    Common inflammatory rheumatological conditions in-
clude SpA, RA, vasculitis, systemic lupus erythematosus, 
and mixed connective tissue disease, where along with spi-
nal and peripheral joints, periarticular soft tissues also can 
be involved. Soft tissue lesions in the form of enthesitis 
are more common in SpA than in other inflammatory joint 
disorders, and are mostly distributed in the Achilles tendon 
and plantar fascia. It also can be seen in the head/base 
of the metatarsal bone, origin of the adductor muscle of 
the thigh, extensor tendon, anterior superior iliac spine, 
iliac crest, symphysis pubis, or de Quervain’s tenosynovial 
sheath, etc. [17]. Compressive neuropathy due to soft tis-
sue inflammation at the nerve tunnel is common in RA [18]. 
In inflammatory rheumatological conditions, spine and pe-
ripheral joints respond well to steroids/NSAIDs (non-ster-
oidal  anti-inflammatory  drugs)  and  DMARDs  (disease 
modifying  anti-rheumatic  drugs)  [19,20].  Pulsed  steroid 
(375-1,000 mg) in 5% dextrose aqua is a treatment option 
in acute flare-ups of RA/SpA, usually practiced for 3-5 
consecutive days [21]. Osteoarthritis predominantly affects 
t h e  w e i g h t  b e a r i n g  l o w e r  e x t r e m i t y  j o i n t s  a n d  i s  m o r e  
common in the knee than in the hip, ankle, or foot joints. 
In the upper extremity, OA usually involves the acromio-
clavicular joint. Along with oral medications, I/A steroids 
and local anesthetics can be effective in both inflammatory 
and degenerative joint disorders [20]. I/A injection of so-
dium hyaluronate (20 mg/2 ml) is a treatment option in OA 
of the knee  responding  poorly  to  available conservative 
approaches [22]. To reduce joint pain and repair damaged 
cartilage, at least 3 injections should be given in each joint 
for three successive weeks [22]. I/A ozone prolotherapy is 
also effective in knee OA, as described in some research 
articles [23,24]. After aspiration, bandaging can be done 
t o  p r e v e n t  r e c u r r e n t  e f f u s i o n ,  f o l l o w e d  b y  r e s t r i c t i o n  o f 
knee weight bearing activities for the next 24-48 hours. 
Common complications during and after joint injection are 
aspiration pain, recurrent effusion, transient rise of blood 
pressure (steroid-induced), acute flare-up, injection site 
pain,  overlying  skin  depigmentation,  joint  infection,  or 
avascular necrosis. Aspiration pain is more common if joint 
procedures  are  done  without  local  anesthesia.  Acute 
flare-up is possible within the first 24-72 hours following 
the procedure, and generally resolves spontaneously, but 
can be managed with local application of ice/cold com-
presses. Recurrent effusion is more common in deformed 
joints. Overlying skin depigmentation has been reported 
following triamcinolone- mediated joint/soft tissue inter-
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different inflammatory rheumatological conditions and 600 
cases  of  degenerative  peripheral  joint  disorders  were 
treated in the pain clinic. In both of these conditions, the 
most common site of peripheral joint intervention was the 
knee. Soft tissue rheumatism (STR), soft tissue lesion, and 
compressive  neuropathy  were  common  in  inflammatory 
rather  than  degenerative  peripheral  joint  disorders. 
Inflammatory  soft  tissue  lesions  were  commonly  dis-
tributed in the plantar fascia (30), de Quervain’s tenosy-
novial sheath (10), and trigger finger (6). Heel enthesitis 
(plantar fasciitis and Achilles tendinitis) was common in 
SpA. All compressive neuropathy in the form of CTS was 
classified as RA. I/A steroids were given to reduce joint 
pain, and the knee joint received a maximum dose (80 mg) 
of methylprednisolone among all peripheral joints. Injection 
of sodium hyaluronate 20 mg/2 ml was given in 10 cases 
of OA of the knee. Of these patients, only 2 received the 
recommended dose (at least 3 injections for 3 consecutive 
weeks). Pulsed steroids were given only in 10 cases (3.3%) 
of RA and SpA during acute flare-ups. To avoid develop-
ment of avascular necrosis, we did not perform any ster-
oidal intervention in the hip joint. During and following joint 
procedures, reported complications were aspiration pain, 
recurrent  effusion,  flare-ups,  and  skin  depigmentation. 
Recurrent effusion was common in deformed knee joints 
(58). Flare-ups were documented within the first 24 hours. 
Aspiration pain was more common in the knee joint at the 
midpoint of the procedure, as we didn’t use local anes-
thetic before joint injection. Skin depigmentation was found 
more frequently with triamcinolone acetonide preparation.
    Non-infectious and non-inflammatory STR [26] has 
two basic patterns: compressive neuropathy and soft tis-
sue lesion proper. Compressive neuropathy is commonly 
distributed in the carpal tunnel, tarsal tunnel, fibular neck 
(compression of the common peroneal nerve at the fibular 
neck), Guyon’s canal (ulnar border of the wrist compress-
ing  the  ulnar  nerve)  [27],  anterior  superior  iliac  spine 
(meralgia  paresthetica),  and  interdigital  nerve  (Morton’s 
nerve).  Compressive  neuropathy  can  also  sometimes  be 
a s s o c i a t e d  w i t h  c e r v i c a l  a n d  l u m b a r  s p i n a l  s t e n o s i s ,  
termed double crush phenomenon [27]. On the other hand, 
soft  tissue  lesion  proper  is  usually  distributed  in  the 
wrist/hand (de Quervain’s tenosynovial sheath, flexor ten-
don), shoulder girdle (bicipital tendon, supraspinatus ten-
don), elbow (lateral and medial epicondyle), heel (plantar 
fascia, Achilles tendon), extensor tendon of hand/foot dor-
sum, knee (anserine bursa), and shoulder joint capsule [28, 
29]. All of these soft tissues can be involved in different 
localized or systemic musculoskeletal disorders. In addition 
to inflammatory/degenerative rheumatological conditions, 
STR can also be found in endocrine disorders, overuse, and 
trauma, or it may be idiopathic [18,29,30]. Adhesive cap-
sulitis is the leading presentation of idiopathic STR in some 
co-morbid  conditions,  such  as  DM,  hypo-  or  hyper-
thyroidism, stroke, dyslipidemia, or ischemic heart disease. 
Patients usually complain of shoulder/arm pain with re-
stricted mo v emen ts im pairing daily acti vities [27]. Other 
than adhesive capsulitis, MPS is another common pattern 
of idiopathic STR [30]. In overuse syndrome, it commonly 
i n v o l v e s  t h e  s h o u l d e r  g i r d l e  ( b i c i p i t a l  t e n d i n i t i s ,  s u p r a -
spinatus tendinitis), elbow (tennis and golfer’s elbow), and 
wrist/hand  (de  Quervain’s  tenosynovitis,  trigger  fin-
ger/trigger thumb) [31-33]. All of these soft tissues can 
also be involved in DM, hypothyroidism, acromegaly, or 
postmenopausal women, due to associated hormonal im-
balance [27,34]. Along with oral medications (NSAIDs, an-
a l g e s i c  o r  n e u r o p a t h i c  a g e n t s ) ,  p h y s i c a l  i n t e r v e n t i o n s  
(therapeutic pulsed ultrasound), therapeutic exercise, and 
IL steroid/ozone or prolotherapy can also be effective in 
managing this, a common rheumatological manifestation. 
When all of these approaches have failed, then surgery can 
be done to release soft tissues [27,28]. Following local ste-
roid injection, common complications are skin depigmenta-
tion, soft tissue injury, injection site pain, flare-ups, and 
infection. Rupture of the plantar fascia is also possible af-
ter local steroid injection. In our study, idiopathic soft tis-
sue lesions were treated in 190 cases (63.3%), and the 
most common presentation was adhesive capsulitis (90). 
MPS was diagnosed in 50 cases. Soft tissue lesions due 
to overuse and blunt trauma were seen in 50 cases, and 
most common (15) in the elbow region. In the lower back, 
p a i n  w a s  d u e  t o  l u m b a r  l i g a m e n t o u s  s p r a i n  a n d  M P S .  
Anserine bursitis was diagnosed in 5 cases of OA of the 
knee. STR in the form of trigger finger/trigger thumb (35) 
and compressive neuropathy (15) was diagnosed in 50 pa-
tients having endocrine problems. Traumatic compressive 
n e u r o p a t h y  w a s  s e e n  i n  1 0  c a s e s .  O t h e r  t h a n  t r a u m a / 
overuse or endocrinopathy, compressive neuropathy can 
also be seen in cervical and lumbar spondylosis, and in our 
recent study all 5 cases of TTS were found in lumbar spinal 
stenosis, with a final diagnosis of d ouble crush pheno-
menon. Idiopathic compressive neuropathy was also seen MAB Siddiq, et al / Physiatric Experience in Pain Intervention 213
in  20  patients.  Following  IL  steroid  injection,  reported 
complications were skin depigmentation, recurrence, acute 
flare-up, and failure. Skin depigmentation was seen in 20 
cases (69.0%) following triamcinolone injection. 
    The basic patterns of LBP are localized, radicular, and 
referred. Localized and radicular LBP occur due to spine 
degeneration, inflammation, infection, trauma, tumor, or 
d i s c  h e r n i a t i o n .  R a d i c u l o p a t h y  c a n  b e  b o t h  d e r m a t o m a l  
and non-dermatomal; dermatomal pain follows the corre-
sponding nerve root, whereas in non-dermatomal radicul-
opathy, the pain is due to involvement of multiple nerve 
roots or a single nerve, and doesn’t follow a single nerve 
root [35]. One of the common but rarely considered causes 
of non-dermatomal radicular LBP is piriformis syndrome, 
which may develop following low back trauma, and in which 
the patient may feel discomfort in sitting for long periods, 
standing, walking, and even in forward bending [36]. Along 
with NSAIDs, muscle relaxants, and neuropathic agents, 
radiculopathy can be treated with physical interventions 
(therapeutic  ultrasound,  transcutaneous  electrical  nerve 
stimulation) and therapeutic exercises [37]. F or radicular 
lower back pain, epidural injections using methylpredni-
solone and local anesthetics may be helpful. Lumbar epi-
dural injections can be performed using anatomical land-
marks (LOR, loss of resistance), and also with C-arm fluo-
roscopy, and are commonly performed at the L3-4/L4-5 
level [14, 15]. This treatment is effective in spinal stenosis, 
PLID, and degenerative disc disease, but less effective in 
spondylolisthesis [38,39]. On the other hand, in piriformis 
syndrome, respective muscle intervention can be done with 
steroids and local anesthetics using anatomical landmarks, 
motor  stimulation,  C-arm  fluoroscopy,  and  ultrasound 
guidance [40]. After steroidal intervention, recurrence of 
piriformis  muscle  pain  is  common,  requiring  botulinum 
toxin injection [41]. Piriformis injection followed by pir-
iformis muscle stretching exercises may provide the max-
imum benefit. Referred LBP is mostly due to sacroiliac and 
facet  arthropathy,  but  it  can  also  be  viscerogenic  in 
source. F acet and sacroiliac arthropathy can be treated 
with I/A steroid injections or radiofrequency ablation of the 
respective joint/nerve supplying the joint [42,43]. Radicul-
opathy due to disc prolapse not responding to epidural ste-
roids can be managed with ozone nucleolysis [44]. IDET is 
a good option for internal disc disruption, and non-trau-
matic vertebral body fracture can be managed with verte-
broplasty [45,46]. During and after epidural/facet joint in-
jection, common complications are headache, neurogenic 
shock, thecal sac puncture, temporary dizziness, multiple 
pricks, vasovagal reaction, infection, potential weight gain, 
transient  rise  of  blood  pressure/hyperglycemia  (steroid- 
induced), and failure, among others [47,48]. In the current 
study, a total of 60 patients with radicular LBP were treat-
ed in the pain clinic by IPM. A common presentation of 
dermatomal radiculopathy was lumbar spinal stenosis (50, 
83.3%), due to degenerative disc disease, PLID, spondylo-
listhesis, spondylodiscitis, and vertebral body fracture. All 
cases of dermatomal radiculopathy except only one in-
fectious lumbar spondylodiscitis were treated with lumbar 
epidural injection using the LOR technique. The majority 
of lumbar interlaminar epidural injections were performed 
at L3-4 (35, 71.4%). It takes about 1 week (mean 5 days) 
to initiate pain reduction, and a patients’ reported 70% re-
duction of pain was sustained in 27 patients even after 6 
months following the intervention. This pain reduction was 
sustained for only 4 months in another 13 patients, with 
a  repeated  epidural  injection  necessary  by  this  time. 
Numerical pain reduction score was below 50% in 4 cases 
of spondylolisthesis. In piriformis syndrome, the average 
duration between intervention and at least 50% pain im-
provement was 5 days. Out of 10 patients, 6 obtained 70% 
r e p o r t e d  p a i n  r e d u c t i o n ,  w h i c h  w a s  m a i n t a i n e d  f o r  a n  
average of 3 months with NSAIDs (diclofenac sodium) and 
muscle  relaxants  (tolperison  and/or  cyclobenzaprine). 
Common  post-procedural  complications  were  multiple 
pricks in lumbar epidural injections, headache, flare-ups, 
and partial recovery. 
    It can be concluded that IPM is gaining popularity 
throughout the world in the management of painful mus-
c u l o s k e l e t a l  c o n d i t i o n s .  A l o n g  w i t h  a n e s t h e s i o l o g i s t s ,  
physiatrists have a definitive role in IPM. To better serve 
pain sufferers, the physiatrist must work hand-in-hand 
with other specialties. In this article, we describe a few 
procedures performed in the PMR department of a tertiary 
medical college hospital in Bangladesh using only anatomi-
cal landmarks, so accuracy was not ensured. We did not 
perform any intervention in a facet joint, sacroiliac joint, 
sympathetic  ganglion,  vertebral  body,  or  intervertebral 
disc using radiofrequency ablation, IDET, ozone nucleol-
ysis, or steroid injection because of: (1) Lack of a C-arm 
facility in the PMR department; (2) Greater reliance on oral 
medications; (3) Lack of knowledge of diagnostic muscu-
loskeletal ultrasonogram or fluoroscopy; (4) Lack of ex-214 Korean J Pain Vol. 24, No. 4, 2011
posure  to  interventional  pain  procedures;  and  (5)  Poor 
knowledge about the spectrum of IPM. Therefore, we rec-
ommend: (1) Development of an IPM unit in the PMR de-
partment; (2) Greater emphasis on IPM as a separate entity; 
(3) Increased  collaboration  with  other  institutes/depart-
ments dealing with interventional procedures both at home 
and abroad; (4) Development of skills in IPM through spe-
cial training; and (5) Training in diagnostic musculoskeletal 
ultrasonogram/electrodiagnosis to ensure a safe and accu-
rate  interventional  approach,  with  an  ultimate  goal  of 
serving pain sufferers to ensure them a better quality of 
life.
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